136 related articles for article (PubMed ID: 32375876)
1. Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis.
Wee CW; Kim KS; Kim CY; Han JH; Kim YJ; Kim IA
Radiat Oncol; 2020 May; 15(1):98. PubMed ID: 32375876
[TBL] [Abstract][Full Text] [Related]
2. Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment.
Kim KS; Wee CW; Seok JY; Hong JW; Chung JB; Eom KY; Kim JS; Kim CY; Park YH; Kim YJ; Kim IA
Radiat Oncol; 2018 Feb; 13(1):29. PubMed ID: 29463267
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy.
Hofmaier J; Kantz S; Söhn M; Dohm OS; Bächle S; Alber M; Parodi K; Belka C; Niyazi M
Radiat Oncol; 2016 Sep; 11(1):118. PubMed ID: 27609371
[TBL] [Abstract][Full Text] [Related]
4. Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience.
Briere TM; McAleer MF; Levy LB; Yang JN
Radiat Oncol; 2017 May; 12(1):79. PubMed ID: 28464840
[TBL] [Abstract][Full Text] [Related]
5. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
[TBL] [Abstract][Full Text] [Related]
6. Role of hippocampal location and radiation dose in glioblastoma patients with hippocampal atrophy.
Le Fèvre C; Cheng X; Loit MP; Keller A; Cebula H; Antoni D; Thiery A; Constans JM; Proust F; Noel G
Radiat Oncol; 2021 Jun; 16(1):112. PubMed ID: 34158078
[TBL] [Abstract][Full Text] [Related]
7. Inclined head position improves dose distribution during hippocampal-sparing whole brain radiotherapy using VMAT.
Kim KS; Seo SJ; Lee J; Seok JY; Hong JW; Chung JB; Kim E; Choi N; Eom KY; Kim JS; Kim IA
Strahlenther Onkol; 2016 Jul; 192(7):473-80. PubMed ID: 27221313
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.
Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G
Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
[TBL] [Abstract][Full Text] [Related]
10. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques.
Yuen AHL; Wu PM; Li AKL; Mak PCY
Radiat Oncol; 2020 Feb; 15(1):42. PubMed ID: 32070385
[TBL] [Abstract][Full Text] [Related]
11. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
[TBL] [Abstract][Full Text] [Related]
13. A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.
Monjazeb AM; Ayala D; Jensen C; Case LD; Bourland JD; Ellis TL; McMullen KP; Chan MD; Tatter SB; Lesser GJ; Shaw EG
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):743-8. PubMed ID: 21236604
[TBL] [Abstract][Full Text] [Related]
14. A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol.
Guan Y; Pan M; Yang J; Lu Q; Han L; Liu Y; Li J; Zhu H; Gong X; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
BMC Cancer; 2022 Jul; 22(1):827. PubMed ID: 35906549
[TBL] [Abstract][Full Text] [Related]
15. Assessment of multi-criteria optimization (MCO) for volumetric modulated arc therapy (VMAT) in hippocampal avoidance whole brain radiation therapy (HA-WBRT).
Zieminski S; Khandekar M; Wang Y
J Appl Clin Med Phys; 2018 Mar; 19(2):184-190. PubMed ID: 29411526
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy, coplanar volumetric-modulated arc, therapy, and noncoplanar volumetric-modulated arc therapy in, glioblastoma: A dosimetric comparison.
Hou Y; Zhang Y; Liu Z; Yv L; Liu K; Tian X; Lv Y
Clin Neurol Neurosurg; 2019 Dec; 187():105573. PubMed ID: 31706107
[TBL] [Abstract][Full Text] [Related]
18. Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic circuit and neural stem cell compartment.
Marsh JC; Ziel GE; Diaz AZ; Wendt JA; Gobole R; Turian JV
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):378-83. PubMed ID: 23721150
[TBL] [Abstract][Full Text] [Related]
19. Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.
Dumane VA; Bakst R; Green S
PLoS One; 2018; 13(10):e0205770. PubMed ID: 30339705
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
